Oral pharmaceutical composition of a poorly water-soluble active substance

Details for Australian Patent Application No. 2007263016 (hide)

Owner Solvay Pharmaceuticals B.V. Panacea Biotec Ltd.

Inventors Jain, Rajesh; Jindal, Kour C.; Gorissen, Henricus R. M.; Talwar, Munish; Singh, Amarjit

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007263016

PCT Pub. Number WO2007/147873

Priority 1473/DEL/2006 22.06.06 IN; 06115881.2 22.06.06 EP; 60/815,579 22.06.06 US

Filing date 21 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/147873 Priority application(s): WO2007/147873

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263017-Pyridine and pyrazine derivatives as MNK kinase inhibitors

2007263013-Process for the manufacture of 1,2-dichloroethane